NervGen Pharma to Present at the Unite 2 Fight Paralysis 19th Annual Science & Advocacy Symposium Focused on Spinal Cord Injury
NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative ...
NervGen Pharma to Present at the 63rd International Spinal Cord Society Annual Scientific Meeting
NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative ...
Here's Why We're Not At All Concerned With NervGen Pharma's (CVE:NGEN) Cash Burn Situation
So should NervGen Pharma ( CVE:NGEN) shareholders be worried about its cash burn? In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company ...
Macy's to hire more than 31,500 employees for holiday season
U.S. retailers are expected to hire fewer workers this holiday season than in 2023 due to a softer labor market and tighter ...
Bank of Canada must be transparent to maintain trust, external deputy governor says
A senior Bank of Canada official says the central bank must be rigorous and transparent in order to maintain the public's ...
Stifel Nicolaus Sticks to Its Buy Rating for Cipher Pharmaceuticals (CPHRF)
Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Cipher Pharmaceuticals (CPHRF – Research Report) today and set a price ...
Stifel Nicolaus Keeps Their Buy Rating on Savaria (SIS)
Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Savaria (SIS – Research Report) today and set a price target of ...